A case of wet purpura due to etoricoxib induced thrombocytopenia

Authors

  • Robin George Manappallil Consultant - Physician, Department of Medicine, National Hospital, Calicut, Kerala 673001 India http://orcid.org/0000-0003-3973-6800
  • Vinod Krishnan Professor and Head, Department of Medicine, KMCT Medical College, Calicut, Kerala 673602

DOI:

https://doi.org/10.3126/ajms.v7i5.14674

Keywords:

Etoricoxib, Drug induced thrombocytopenia, Wet purpura

Abstract

Etoricoxib  is  a  selective  cyclo-oxygenase  2  inhibitor,  commonly  used  in  treatment  of  rheumatoid  arthritis,  gout  and  back  pain.  Pretibial  edema  and  erythema,  gastric  irritation  and  risks  of  cardiovascular  and  cerebrovascular  thrombotic  events  are  some  of  the  reported  adverse  effects  due  to  etoricoxib.  This  case  report  is  regarding  a  patient  who  presented  with  wet  purpura  following  etoricoxib  intake.  Drug  induced  thrombocytopenia  is  an  unreported  side  effect  of  etoricoxib.

Asian Journal of Medical Sciences Vol.7(5) 2016 135-137

Downloads

Download data is not yet available.
Abstract
906
PDF
1440

Author Biography

Robin George Manappallil, Consultant - Physician, Department of Medicine, National Hospital, Calicut, Kerala 673001 India

Consultant - Physician,

Department of Medicine

Downloads

Additional Files

Published

2016-08-31

How to Cite

Manappallil, R. G., & Krishnan, V. (2016). A case of wet purpura due to etoricoxib induced thrombocytopenia. Asian Journal of Medical Sciences, 7(5), 135–137. https://doi.org/10.3126/ajms.v7i5.14674

Issue

Vol. 7 No. 5 (2016)

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).